via Stanford University
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first studies on the topic.
The findings were published in the Journal of Medical Internet Research on January 29.
The Warrior Watch Study found that subtle changes in a participant’s heart rate variability (HRV) measured by an Apple Watch were able to signal the onset of COVID-19 up to seven days before the individual was diagnosed with the infection via nasal swab, and also to identify those who have symptoms.
“This study highlights the future of digital health,” says the study’s corresponding author Robert P. Hirten, MD, Assistant Professor of Medicine (Gastroenterology) at the Icahn School of Medicine at Mount Sinai, and member of the Hasso Plattner Institute for Digital Health at Mount Sinai and the Mount Sinai Clinical Intelligence Center (MSCIC). “It shows that we can use these technologies to better address evolving health needs, which will hopefully help us improve the management of disease. Our goal is to operationalize these platforms to improve the health of our patients and this study is a significant step in that direction. Developing a way to identify people who might be sick even before they know they are infected would be a breakthrough in the management of COVID-19.”
The researchers enrolled several hundred health care workers throughout the Mount Sinai Health System in an ongoing digital study between April and September 2020. The participants wore Apple Watches and answered daily questions through a customized app. Changes in their HRV—a measure of nervous system function detected by the wearable device—were used to identify and predict whether the workers were infected with COVID-19 or had symptoms. Other daily symptoms that were collected included fever or chills, tiredness or weakness, body aches, dry cough, sneezing, runny nose, diarrhea, sore throat, headache, shortness of breath, loss of smell or taste, and itchy eyes.
Additionally, the researchers found that 7 to 14 days after diagnosis with COVID-19, the HRV pattern began to normalize and was no longer statistically different from the patterns of those who were not infected.
“This technology allows us not only to track and predict health outcomes, but also to intervene in a timely and remote manner, which is essential during a pandemic that requires people to stay apart,” says the study’s co-author Zahi Fayad, PhD, Director of the BioMedical Engineering and Imaging Institute, Co-Founder of the MSCIC, and the Lucy G. Moses Professor of Medical Imaging and Bioengineering at the Icahn School of Medicine at Mount Sinai.
The Warrior Watch Study draws on the collaborative effort of the Hasso Plattner Institute for Digital Health and the MSCIC, which represents a diverse group of data scientists, engineers, clinical physicians, and researchers across the Mount Sinai Health System who joined together in the spring of 2020 to combat COVID-19. The study will next take a closer look at biometrics including HRV, sleep disruption, and physical activity to better understand which health care workers are at risk of the psychological effects of the pandemic.
Original Article: Mount Sinai Study Finds Wearable Devices Can Detect COVID-19 Symptoms and Predict Diagnosis
More from: Icahn School of Medicine at Mount Sinai
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Detecting Covid-19 symptoms
- DoD partners with Detect-Ion to develop Point-of-Care Breath Diagnostics for Early Detection of Infected Warfighters
The recent COVID-19 pandemic has highlighted the need to rapidly detect infected humans to intervene early before severe conditions develop and to mitigate the spread of infections across a larger ...
- Do You Still Need to Test for COVID-19?
While COVID-19 is no longer a public health emergency, experts recommend following some health protocols—like testing—in an effort to keep everyone healthy and safe. There are a variety of COVID ...
- Study confirms ongoing brain inflammation associated with long COVID
A new CAMH study published in the journal JAMA Psychiatry found elevated levels of inflammation in the brain of patients who report persistent symptoms of long COVID.
- Symptoms linger 2 years after COVID-19 for 1 in 6 unvaccinated people
People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.
- Simple blood test can detect two out of three cancers, trial by Britain's NHS finds
Clinical trials by Britain's National Health Service of a U.S.-developed early cancer-detection blood test have found it can detect two out of three cancers.
Go deeper with Google Headlines on:
Detecting Covid-19 symptoms
[google_news title=”” keyword=”detecting Covid-19 symptoms” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
The future of digital health
- “Digital health is very important now…”: Bharat Biotech Executive Chairman Dr Krishna Ella at G20 Health Working Group Meet
The Executive Chairman of Bharat Biotech, Dr Krishna Ella on Tuesday highlighted the Government of India’s emphasis on digital health at the G20 third Health Working Group Meeting in Telangana’s ...
- WHO, European Commission launch landmark digital health partnership
The World Health Organization (WHO) and European Commission have announced today the launch of a landmark digital health partnership.
- Accelerating the digitisation of healthcare with digital health platforms
Digital platforms are set to be the gamechangers in achieving digitisation of healthcare. The integration of digital health platforms is key, enabling hospitals and healthcare systems to effectively ...
- Digital Biomarkers: The Key to Delivering on the Promise of Personalized Medicine
Digital biomarkers today serve as a valuable monitoring tool, providing details about a patient’s general health and response to treatment. But, as technology continues to develop, they could fuel ...
- Silicon Valley company equips health care innovators and professionals for the future
Anatomage, a Silicon Valley-based company, has been reinventing the methods of human anatomy education with interactive and on-demand devices that deliver vital information to enhance patient care.
Go deeper with Google Headlines on:
The future of digital health
[google_news title=”” keyword=”the future of digital health” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
